Position in PLRX
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$444,412
-$423,955 QoQ
Shares Held
352,708
-50.4% QoQ
Ownership
0.570%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in PLRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $8,548,750,242 across 347 Biotechnology names. PLRX ranks #252 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,878,183 | $1,285,223,834 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,189,584 | $919,120,177 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
966,912 | $319,922,169 | |
| 4 | ARGX |
Argenx SE
|
400,117 | $292,185,437 | |
| 5 | INSM |
INSMED Inc
|
1,502,281 | $245,652,986 | |
| 6 | CYTK |
Cytokinetics Inc
|
3,125,436 | $205,997,485 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,014,800 | $191,847,936 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,913,109 | $188,274,232 |
All Filings in PLRX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $444,412 | 352,708 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $868,367 | 711,777 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,047,922 | 708,056 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $557,414 | 480,530 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,242,992 | 920,736 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,593,266 | 120,977 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $7,036,471 | 627,696 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $6,495,633 | 604,245 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $7,417,428 | 497,814 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,418,556 | 78,330 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $644,787 | 37,185 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,816,004 | 100,221 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,035,484 | 76,522 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $411,747 | 21,301 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $1,469,757 | 70,357 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $109,728 | 13,699 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $125,030 | 17,836 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $349,326 | 25,876 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $327,605 | 19,408 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $251,130 | 8,624 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $269,645 | 6,856 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $58,526 | 2,576 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $14,110 | 623 | Shares | Defined | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||